Silvan Tuerkcan

Stock Analyst at Citizens

(4.43)
# 358
Out of 5,182 analysts
177
Total ratings
48.55%
Success rate
22.55%
Average return

Stocks Rated by Silvan Tuerkcan

Terns Pharmaceuticals
Mar 26, 2026
Downgrades: Market Perform
Price Target: n/a
Current: $52.94
Upside: -
CRISPR Therapeutics AG
Dec 23, 2025
Reiterates: Market Outperform
Price Target: $86
Current: $52.06
Upside: +65.19%
Nuvation Bio
Nov 20, 2025
Maintains: Market Outperform
Price Target: $8$10
Current: $4.56
Upside: +119.30%
enGene Therapeutics
Nov 12, 2025
Maintains: Market Outperform
Price Target: $18$21
Current: $6.96
Upside: +201.72%
Intellia Therapeutics
Nov 7, 2025
Maintains: Market Outperform
Price Target: $29$21
Current: $13.20
Upside: +59.09%
Taysha Gene Therapies
Nov 5, 2025
Maintains: Market Outperform
Price Target: $6$8
Current: $6.30
Upside: +26.98%
Benitec Biopharma
Nov 4, 2025
Maintains: Market Outperform
Price Target: $20$22
Current: $12.17
Upside: +80.77%
Jasper Therapeutics
Sep 22, 2025
Maintains: Market Outperform
Price Target: $12$6
Current: $0.93
Upside: +545.37%
Phreesia
Sep 8, 2025
Maintains: Market Outperform
Price Target: $30$34
Current: $9.42
Upside: +260.93%
IDEAYA Biosciences
Sep 8, 2025
Maintains: Market Outperform
Price Target: $41$45
Current: $29.04
Upside: +54.96%
Reiterates: Market Outperform
Price Target: $50
Current: $44.93
Upside: +11.28%
Reiterates: Market Outperform
Price Target: $15
Current: $7.45
Upside: +101.34%
Maintains: Market Outperform
Price Target: $10$6
Current: $3.69
Upside: +62.60%
Reiterates: Market Outperform
Price Target: $9
Current: $5.17
Upside: +74.08%
Downgrades: Market Perform
Price Target: $120
Current: $14.38
Upside: +734.49%
Reiterates: Market Outperform
Price Target: $17
Current: $1.90
Upside: +794.74%
Initiates: Market Outperform
Price Target: $4
Current: $2.51
Upside: +59.36%
Reiterates: Market Outperform
Price Target: $21
Current: $13.03
Upside: +61.17%
Downgrades: Market Perform
Price Target: n/a
Current: $3.01
Upside: -
Reiterates: Market Outperform
Price Target: $6
Current: $4.00
Upside: +50.00%
Maintains: Buy
Price Target: $240$280
Current: $67.25
Upside: +316.36%
Maintains: Market Outperform
Price Target: $18$18
Current: $11.01
Upside: +63.49%